Key result
Serum omentin-1 levels were significantly lower in type 2 diabetic patients with retinopathy compared to those without, and in proliferative versus non-proliferative retinopathy.
Why the study?
Are serum omentin-1 levels associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes?
Observational (n=95)
Are serum omentin-1 levels associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes?
Serum omentin-1 levels are inversely associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes.
May support omentin-1 as retinopathy biomarker; leaves open predictive value and clinical utility in type 2 diabetes.
BackgroundDiabetic retinopathy (DR) is one of the most common and serious micro vascular complication affecting type 2 diabetic patients.The literature on adipokines as a possible mechanism in the pathogenesis of DR is contradictory.We are in need for more explanation about the pathogenesis of DR and also in need for reliable biomarker for early diagnosis of such complication.The aim of this work was to study the serum level of omentin-1 and its relation to diabetic retinopathy in type 2 diabetes mellitus (type 2 DM).Patients and methodsThis study was conducted on 75 type 2 DM patients; 20 healthy subjects served as a control group. All participants were classified into 4 groups:• Group1: Included 25 type 2 diabetics without retinopathy.• Group2: Included 25 type 2 diabetics with non proliferative diabetic retinopathy (NDPR).• Group 3: Included 25 type 2 diabetics with proliferative diabetic retinopathy (PDR).• Group 4: Included 20 healthy subjects as a control group.Thorough history taking and physical examination with calculation of body mass index (BMI), investigations were done including serum creatinine, lipid profile, glycosylated haemoglobin (HbAIc), C-reactive protein (CRP), urine albumin creatinine ratio (UACR) and serum omentin-1. Fundus examination was carried out by an expert ophthalmologist.ResultsSerum omentin-1 level was significantly lower in diabetic patients compared with the control, and in DR compared with diabetics without DR and in PDR compared with NPDR.There was a negative significant correlation between serum omentin-1 level and BMI, HbA1c, CRP, total cholesterol, low density lipoprotein (LDL) and Serum triglycerides (TG) and positive significant correlation with high density lipoprotein (HDL).ConclusionsFrom this study we can conclude that serum omentin-1 is significantly lower in patients with DR compared with diabetics without retinopathy and in PDR patients compared with NPDR patients.Also, there is a negative significant correlation between serum omentin-1 and HbAIc, BMI, CRP and some lipid parameters.
No takes yet. Share an insight, caveat, or question.
Korany et al. (2018) conducted an observational in Type 2 diabetes mellitus and diabetic retinopathy (n=95). Serum omentin-1 level vs. Healthy controls and diabetic patients without retinopathy was evaluated on Serum omentin-1 level. Serum omentin-1 levels were significantly lower in type 2 diabetic patients with retinopathy compared to those without, and in proliferative versus non-proliferative retinopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: